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order to preserve continence and potency. The specimen was
then removed intact through the camera port by using a
retrieval bag. Accurate hemostatic control was achieved and a
tube drain was positioned. Console time and estimated blood
loss were, respectively, 120 minutes and 50 cc; no
intraoperative complications were recorded. The post-
operative course was uneventful and the patient was
discharged on the fourth postoperative day with normal blood
tests and spontaneous voiding. A two-year follow-up showed
no evidence of disease recurrence. At present, the patient is
free of symptoms with full preservation of continence and
potency. Histopathological examination revealed a
7.0×4.5×4.5 cm cystic SV cystoadenoma (Figure 2). 
No significant cytologic atypia, mitotic activity or necrosis
were present. The proliferation index was <1%. Review of
the Literature: A systematic review of the English-language
literature was performed using the Medline, Embase and
Web of Science databases up to December 2014. Twenty
case reports have been published in literature on SV
cystoadenoma (Table I). 
Median patient age and median tumor diameter were 49
years (inter-quartile range (IQR)=42-51) and 7.0 cm (IQR
5.0-12.0), respectively. No perioperative complications were
reported in all the published series. Local recurrence
occurred in 2 cases (10%) after 2 and 3 years, respectively.
The differential use of diagnostic investigations and surgical
approaches for SV cystoadenoma in the published series is
shown in Figure 3. Discussion and Conclusion: Primary
tumors of SVs are very rare and the differential diagnosis
must be based on a multimodality approach. Most cases of
SV cystoadenoma were managed with open surgery through
transvesicle/retrovesicle approaches or radical cysto-prostato-
vesiculectomy. To date, minimally-invasive seminal
vesiculectomy (MISV) is increasingly used for the treatment
of beginning diseases of SVs achieving optimal oncologic
and functional results. Therefore, they could be considered
the new gold standard for the treatment of such rare diseases.
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Introduction/Aim: Benign tumors (BT) of seminal vesicles (SV)
are very rare. Diagnosis could be challenging and often requires
the histopathological analysis after surgical excision. The best
surgical treatment is still matter of discussion. The aim of this
review is to analyze the current strategies for diagnosis and
treatment of such tumors. Materials and Methods: A systematic
review of English literature was performed using the Medline,
Embase and Web of Science databases up to October 2014. Use
of diagnostic investigations, options of surgical management,
perioperative complications rate and oncologic outcomes were
analyzed for each tumor histotype. Results: Fifty-eight case
reports have been published in literature on BTs of SVs (Table I).
Of these, 5 were excluded from the analysis due to lack of data.
Cystoadenoma was found in 20 cases (38%), leiomyoma in 10
(19%), schwannoma in 8 (15%), mixed epithelial-stromal tumor
in 5 (9%), phyllodes tumor in 4 (8%) and other BTs in 6 (11%)
(Figure 1). Median patient age and median tumor diameter were
50 years (range=23-79) and 5.0 cm (range=2.0-29.0),
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Figure 1. (Abstract 116).
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Table I. Overview of the 53 published series on benign tumors of seminal vesicles included in the analysis.
Histopathological Number of Patients’ age Tumor size Number of studies with Number of studies with 
definition studies (years), (greatest a precise definition a precise definition 
(according to n (%) median (range) diameter) (cm), of the diagnostic of the therapeutic
the study) median (range) strategy n (%) strategy n (%)
Cystoadenoma 20 (38) 49 (23-64) 7.0 (3.0-17.2) 10 (50) 19 (95)
Mixed epithelial - 
stromal tumors (MEST) - 
low grade 5 (9) 61 (37-70) 6.5 (2.5-29.0) 4 (80) 5 (100)
Leiomyoma 10 (19) 61 (37-74) 5.0 (2.0-14.5) 7 (70) 9 (90)
Phyllodes Tumor 4 (8) 43 (39-59) 7.6 (5.5-14.5) 3 (75) 4 (100)
Schwannoma (Neurilemmoma) 8 (15) 45 (31-79) 3.0 (2.2-7.0) 5 (63) 8 (100)
Others (mammary-type 6 (11) 55 (29-79) 5.8 (2.0-14.0) 5 (83) 6 (100)
myofibroblastoma, paraganglioma, 
cystomyoma, low-grade adnexal 
tumour of Wollfian origin, 
solitary fibrous tumor)
All tumors 53 (100) 50 (23-79) 5.5 (2. 0-29.0) 34 (64) 51 (96)
Figure 2. (Abstract 116).
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Figure 3. (Abstract 116).
Table II. Use of diagnostic investigations in the published literature on benign tumors of seminal vesicles. 
Histopathological Ultrasound CT MRI Tumor  Intraoperative Explorative Other strategies Autopsy 
Definition (according (TRUS +/-  n (%) n (%) biopsy biopsies laparotomy (Cystoscopy, n (%)
to the study) Abd US), n (%) n (%) n (%) FNA - Cystology, 
n (%) IV Urography, 
etc.), n (%)
Cistoadenoma 6 (60) 6 (60) 7 (70) 4 (40) 1 (10) 1 (10) 2 (20) 1 (10)
Mixed ephitelial - 
stromal tumors 
(MEST) low-grade 1 (25) 4 (100) 2 (50) 3 (75) 0 (0) 1 (25) 1 (25) 0 (0)
Leiomyoma 3 (43) 4 (57) 4 (57) 2 (29) 0(0) 1 (15) 0 (0) 1 (15)
Phylloides tumors 2 (67) 2 (67) 2 (67) 1 (33) 0 (0) 1 (33) 0 (0) 0 (0)
Schwannoma (neurilemmoma) 5 (100) 4 (80) 3 (60) 4 (80) 0 (0) 0 (0) 0 (0) 0 (0)




adnexal tumour of 
Wolffian origin, solitary 
fibrous tumor)
All tumors 19 (56) 23 (68) 20 (59) 17 (50) 1 (3) 5 (15) 3 (9) 2 (6)
Numbers and percentages are referred to those studies where a precise definition of the diagnostic work-up was clearly stated (see Table I).
TRUS, transrectal ultrasound; CT, computed tomography; MRI, magnetic resonance imaging; CYS, cystoscopy; FNA, fine needle aspiration;
Abd US, abdominal ultrasound.
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Figure 4. (Abstract 116).
Table III. Use of different surgical treatments in the published literature on benign tumors of seminal vesicles. Numbers and percentages are
referred to those studies where a precise definition of the surgical technique was clearly stated (see Table I).
Histopathological Open - Open - Cysto- Laparoscopic Robot- Perioperative Local 
definition Conservative prostato- vesiculectomy assisted complications recurrence 
(according tumorectomy vesiculectomy (LV) laparoscopic (Y=any n (%)
to the study) (with different n (%) n (%) vesiculectomy complication 
approaches) (RALV) n (%) reported; 
n (%) N=no compli-
cations 
reported)
Cistoadenoma 11 (58) 1 (5) 5 (26) 2 (11) N 2 (10)
Mixed ephitelial - 
stromal tumors 
(MEST) low grade 2 (40) 2 (40) 1 (20) 0 (0) N 0 (0)
Leiomyoma 5 (55) 1 (11) 3 (33) 0 (0) N 0 (0)
Phylloides tumors 2 (50) 0 (0) 2 (50) 0 (0) N 0 (0)
Schwannoma 2 (25) 1 (13) 5 (63) 0 (0) N 0 (0)
(neurilemmoma)





tumour of Wolffian 
origin, solitary 
fibrous tumor)
All tumors 26 (51) 6 (12) 17 (33) 2 (4) N 3 (6)
respectively. In 34 papers (64%), the diagnostic work-up was
accurately described (Table II, Figure 2). In these studies,
ultrasound (US) was used in 19 cases (56%), CT scan in 23
(68%), endorectal MRI in 20 (59%), preoperative biopsy in 17
(50%) and intraoperative biopsy in 1 case (3%). Explorative
laparotomy was carried out in 5 cases (15%), while cystoscopy
and other modalities in 3 (9%); finally, 2 cases (6%) were found
at the time of autopsy. In 51 studies (96%), the surgical
technique was well defined (Table III, Figure 3). An open
approach was used in most cases, with conservative
tumorectomy in 26 cases (51%) and radical cysto-prostato-
vesiculectomy in 6 (12%). Laparoscopic and robotic seminal
vesiculectomy (SVe) were performed in 17 (33%) and 2 (4 %)
cases, respectively. Differential use of diagnostic modalities and
surgical techniques for each tumor histotype is presented in
Figures 4 and 5, respectively. No perioperative complications
were reported in the published series. Local recurrence occurred
in 3 cases (6%). Nonetheless, the period of follow-up was
highly variable among the studies.  Discussion and Conclusion:
The first priority during the diagnostic assessment of a SVs
neoplasm is to rule out primary or secondary malignancies. The
overall preoperative evaluation is critical to choose the most
appropriate surgical treatment. MRI and preoperative biopsy are
fundamental in the diagnostic work-up in order to define the
anatomic relationships of the tumor and characterize its nature.
MRI accurately defines the anatomic relationships of the tumor,
while biopsy the characterization of its nature and,
consequently, the more appropriate surgical strategy. SVe is the
recommended treatment for solid masses that are benign on
biopsy, if symptomatic. Although most cases in the literature
were managed with open surgery, nowadays, laparoscopic or
robotic SVe should be considered the gold standard treatment
since they combine a minimally-invasive approach with
excellent oncologic outcomes. Nonethless, the overall grade of
recommendation is currently low as the evidence is still based
on case reports and sporadic case series. 
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Case Report: A 71-year-old man was referred to our centre for
obstructive lower urinary tract symptoms (LUTS) and history of
a vague, chronic discomfort in the right groin and testis since
many years. Prostate-specific antigen (PSA) level was 12 ng/dl.
The diagnostic work up revealed a Gleason score 4+4=8
adenocarcinoma of the prostate. No bone metastases were
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Figure 5. (Abstract 116).
